Announcements Trials
Browse Landscape

Status

Completed 600Recruiting 239Unknown 156Terminated 156Active not recruiting 96Not yet recruiting 62Withdrawn 58Suspended 14No longer available 6Enrolling by invitation 5Approved for marketing 3Available 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Expanded_access 2

Sponsor

Cancer Type

CNS 2

Conditions

Neoplasms 14Carcinoma, Non-Small-Cell Lung 8Sarcoma 6Prostatic Neoplasms 6Pancreatic Neoplasms 6Neuroblastoma 6Multiple Myeloma 6Recurrence 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Melanoma 5Ovarian Neoplasms 4Leukemia, Myeloid, Acute 4Glioblastoma 4Breast Neoplasms 4Stomach Neoplasms 3Small Cell Lung Carcinoma 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Hematologic Neoplasms 3Head and Neck Neoplasms 3Urinary Bladder Neoplasms 2Primary Myelofibrosis 2Pheochromocytoma 2Osteosarcoma 2Non-Muscle Invasive Bladder Neoplasms 2Neuroectodermal Tumors, Primitive 2Neoplasm Metastasis 2Myelodysplastic Syndromes 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Non-Hodgkin 2

Interventions

Vaccination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Available × Glioma × Clear all
NCT06743100 2025-04-02

18F-Floretyrosine Expanded Access Program

Telix Pharmaceuticals (Innovations) Pty Limited

Available
CNS

Glioma

NCT05356312 2024-03-01

Glioblastoma and Individualized Therapies

Zentrum fur Humangenetik Tuebingen

Available
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡